Patient Navigation for Colorectal Cancer Screening
(SCREEN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve colorectal cancer screening rates through a strategy called patient navigation. The focus is on effectively implementing this approach in primary care, particularly for Black and Hispanic/Latino individuals due for screening. Participants will receive guidance and reminders to assist with screening. Those who identify as Black or Hispanic/Latino, are between the ages of 45 and 75, and have a primary care visit at one of the selected clinics might be a good fit for this trial. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance healthcare strategies for diverse communities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that patient navigation is safe for colorectal cancer screening?
Research has shown that patient navigation is a safe and well-accepted approach. Many studies have found that these services help people get screened for colorectal cancer without harmful side effects. Patient navigation guides individuals through the healthcare system, ensuring they receive the right screenings at the right time.
Patient navigation has been tested in various healthcare settings across the U.S. and has effectively increased the number of people getting screened. Importantly, no major negative effects have been linked to these services. This indicates that patient navigation is a safe way to help more people get screened for colorectal cancer.12345Why are researchers excited about this trial?
Researchers are excited about patient navigation for colorectal cancer screening because it offers a personalized approach to overcoming barriers that might prevent people from getting screened. Unlike standard methods that rely on patients to navigate the healthcare system on their own, patient navigation provides tailored support and guidance. This could include helping patients understand their screening options, scheduling appointments, and addressing any logistical or emotional concerns they may have. By directly addressing these obstacles, patient navigation has the potential to significantly increase screening rates and early detection, which is crucial for effective treatment of colorectal cancer.
What evidence suggests that patient navigation is effective for increasing colorectal cancer screening rates?
Research has shown that patient navigation, which participants in this trial may receive, effectively increases colorectal cancer screening rates. One study found that patient navigation led to a 7.3% increase in screenings compared to regular care. This method helps patients overcome obstacles to accessing healthcare services. Previous research also showed that patient navigation significantly improved adherence to screenings, although results varied by location. By guiding patients through the healthcare system, this approach helps fill gaps in cancer screening, especially in communities with less access to healthcare.12678
Are You a Good Fit for This Trial?
This trial is for individuals from racial and ethnic minorities who are due for colorectal cancer screening. It aims to understand how well a patient navigation program works in different primary care clinics.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Patient navigation and patient and provider reminders are rolled out across 15 clinics in a stepped-wedge design
Follow-up
Participants are monitored for colorectal cancer screening completion and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Patient Navigation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medstar Health Research Institute
Lead Sponsor
National Committee for Quality Assurance
Collaborator